Killer immunoglobulin-like receptor (KIR) and KIR–ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2
Titel:
Killer immunoglobulin-like receptor (KIR) and KIR–ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2
Auteur:
Wang, Wei Erbe, Amy K. Gallenberger, Mikayla Kim, KyungMann Carmichael, Lakeesha Hess, Dustin Mendonca, Eneida A. Song, Yiqiang Hank, Jacquelyn A. Cheng, Su-Chun Signoretti, Sabina Atkins, Michael Carlson, Alexander Weiss, Jonathan M. Mier, James Panka, David McDermott, David F. Sondel, Paul M.